載入...
T cells expressing chimeric antigen receptor promote immune tolerance
Cellular therapies based on permanent genetic modification of conventional T cells have emerged as a promising strategy for cancer. However, it remains unknown if modification of T cell subsets, such as Tregs, could be useful in other settings, such as allograft transplantation. Here, we use a modul...
Na minha lista:
| 發表在: | JCI Insight |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society for Clinical Investigation
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5846896/ https://ncbi.nlm.nih.gov/pubmed/29046484 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.92865 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|